Thromboembolic disease and immunotherapy in lung cancer

Por: Garay, D, Boluda, N, Perez, J, Moran, L, Castro, J, Lage, Y, Lavin, D, Rubio, C, Moreno, J, de Soignie, A, de Mena, M, Portero, B, Garrido, M, Puig, C, Martin, A and Canovas, M

---

Publicada: 1 sep 2021 Ahead of Print: 1 sep 2021

---

---

Filiaciones:
Garay, D:
 Univ Jaen, Dept Med Oncol, Jaen, Spain

Boluda, N:
 Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain

Perez, J:
 Fdn Jimenez Diaz, Dept Med Oncol, Madrid, Spain

Moran, L:
 Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Gen Hosp, Madrid, Spain

Castro, J:
 Inst Catalan Oncol Hosp, Dept Med Oncol, Barcelona, Spain

Lage, Y:
 Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain

Lavin, D:
 Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain

:
 Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain

:
 Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain

de Soignie, A:
 Hosp Univ Fuenlabrada, Dept Med Oncol, Madrid, Spain

de Mena, M:
 Hosp Gen Univ Valencia, Dept Med Oncol, Valencia, Spain

Portero, B:
 Hosp Univ Infanta Leonor, Dept Med Oncol, Madrid, Spain

Garrido, M:
 Hosp Univ Jaen, Res Unit, Biostat, Jaen, Spain

Puig, C:
 Hosp Clin Barcelona, Internal Med, Barcelona, Spain

Martin, A:
 Univ Gregorio Maranon, Med Oncol, Fdn Invest Biomed, Gen Hosp, Madrid, Spain

Canovas, M:
 Hosp Univ Morales Meseguer, Dept Med Oncol, Murcia, Spain